BioSpace News Archive

Career Advice

Questions to Ask in an Interview to Assess Whether a Company Supports Diversity and Inclusion

There are several ways to assess if a biotech company has plans in place to diversify their workplace or if they have already achieved this milestone.

November 7, 2019
·
3 min read
·
Kymberlie Krieger
Business

BioSpace Movers & Shakers, Nov. 8

Pharmaceutical, medtech and biotech companies expand their leadership teams with this week’s appointments.

November 7, 2019
·
7 min read
·
Alex Keown
Takeda’s Dengue Vaccine is Promising, but Critics Still Have Concerns

Although the results look very promising, there are still concerns similar to those seen with Sanofi’s Dengvaxia.

November 7, 2019
·
4 min read
·
Mark Terry
Business

France’s Enterome Teams Up with Cancer Center to Validate Immunotherapy Candidate

Enterome and Memorial Sloan Kettering Cancer Center have teamed up to evaluate the potential of gut microbiome-derived antigens for development as potential cancer immunotherapies.

November 7, 2019
·
2 min read
·
Alex Keown
BioMidwest

Abbott Researchers Discover First New HIV Strain in 20 Years

Through the use of cutting-edge gene sequencing, a team of researchers from Abbott Laboratories discovered a new strain of HIV, the first time a new subtype of HIV-1 has been identified in nearly 20 years.

November 7, 2019
·
2 min read
·
Alex Keown
CPhI Worldwide announces the winners of the 16th Pharma Awards

Dr. Ge Li wins ‘CEO of the year’ and John Chiminski a ‘lifetime achievement award’, with a further 11 outstanding winners unveiled

November 7, 2019
·
7 min read
Cells that could lead to new therapies: PromoCell now offers in vitro disease models

PromoCell, a premier manufacturer of human primary cells and cell culture products, now offers cell disease models covering a wide range of diseases including diabetes type 1 and 2, respiratory diseases such as COPD and asthma, as well as cardiomyopathy disease.

November 7, 2019
·
3 min read
ADC Therapeutics Announces Presentations at 61st American Society of Hematology (ASH) Annual Meeting

Presentations highlight lead product candidate ADCT-402 as a single agent and in combination with checkpoint inhibitor durvalumab for relapsed or refractory B-cell non-Hodgkin lymphomas

November 7, 2019
·
5 min read
Biotech Bay

City of Berkeley Awards Contract to NEXGEN Asset Management That Will Enable the City to Eliminate Paper Waste

NEXGEN provides the only software program that combines a computerized maintenance management system with advanced asset management planning capabilities.

November 7, 2019
·
2 min read
Recent Advances in Bavarian Nordic’s Cancer Immunotherapy Platform Published in Nature Communications

A paper discussing recent preclinical advances of Bavarian Nordic’s novel cancer immunotherapy platform was published in the prominent, peer-reviewed, open access journal, Nature Communications.

November 7, 2019
·
2 min read